Low-dose oral etoposide: a new role for an old drug?
ML Slevin
JCO Oct 1 1990: 1607–1609. [PDF]
Intraperitoneal adoptive immunotherapy for peritoneal cancer.
JS Berek
JCO Oct 1 1990: 1610–1612. [PDF]
	Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial
	DH Johnson, FA Greco, J Strupp, KR Hande, and JD Hainsworth
	JCO Oct 1 1990: 1613–1617. [Abstract] [PDF]
	Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity
	RG Steis, WJ Urba, LA VanderMolen, MA Bookman, JW Smith, 2d, JW Clark, RL Miller, ED Crum, SK Beckner, and JE McKnight
	JCO Oct 1 1990: 1618–1629. [Abstract] [PDF]
	Therapy of renal cell carcinoma with interleukin-2 and lymphokine- activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen
	DR Parkinson, RI Fisher, AA Rayner, E Paietta, KA Margolin, GR Weiss, JW Mier, M Sznol, ER Gaynor, and MH Bar
	JCO Oct 1 1990: 1630–1636. [Abstract] [PDF]
	A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma
	MS Ernstoff, S Nair, RR Bahnson, LM Miketic, B Banner, W Gooding, R Day, T Whiteside, T Hakala, and JM Kirkwood
	JCO Oct 1 1990: 1637–1649. [Abstract] [PDF]
	Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study
	DR Parkinson, JS Abrams, PH Wiernik, AA Rayner, KA Margolin, DA Van Echo, M Sznol, JP Dutcher, FR Aronson, and JH Doroshow
	JCO Oct 1 1990: 1650–1656. [Abstract] [PDF]
	Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy
	M Hirsh, A Lipton, H Harvey, E Givant, K Hopper, G Jones, J Zeffren, and D Levitt
	JCO Oct 1 1990: 1657–1663. [Abstract] [PDF]
	Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study
	ME Nesbit, Jr, EA Gehan, EO Burgert, Jr, TJ Vietti, A Cangir, M Tefft, R Evans, P Thomas, FB Askin, and JM Kissane
	JCO Oct 1 1990: 1664–1674. [Abstract] [PDF]
	Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study
	CK Osborne, B Blumenstein, ED Crawford, CA Coltman, Jr, AY Smith, BW Lambuth, and RA Chapman
	JCO Oct 1 1990: 1675–1682. [Abstract] [PDF]
	Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection
	GC Toner, DM Panicek, RT Heelan, NL Geller, SY Lin, D Bajorin, RJ Motzer, HI Scher, HW Herr, and MJ Morse
	JCO Oct 1 1990: 1683–1694. [Abstract] [PDF]
	Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance
	SW Hansen, JG Berthelsen, and H von der Maase
	JCO Oct 1 1990: 1695–1698. [Abstract] [PDF]
	Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas
	LJ Ayash, M Hunt, K Antman, L Nadler, C Wheeler, T Takvorian, A Elias, JH Antin, T Greenough, and JP Eder
	JCO Oct 1 1990: 1699–1706. [Abstract] [PDF]
	Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia
	G Longmore, EC Guinan, HJ Weinstein, RD Gelber, JM Rappeport, and JH Antin
	JCO Oct 1 1990: 1707–1714. [Abstract] [PDF]
	Response of oral leukoplakia to beta-carotene
	HS Garewal, FL Meyskens, Jr, D Killen, D Reeves, TA Kiersch, H Elletson, A Strosberg, D King, and K Steinbronn
	JCO Oct 1 1990: 1715–1720. [Abstract] [PDF]
	Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens
	LX Cubeddu, IS Hoffman, NT Fuenmayor, and AL Finn
	JCO Oct 1 1990: 1721–1727. [Abstract] [PDF]
	Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation
	JA Neidhart, W Kohler, C Stidley, A Mangalik, A Plauche, T Anderson, RW Quenzer, and JJ Rinehart
	JCO Oct 1 1990: 1728–1738. [Abstract] [PDF]
	Pharmacodynamics in cancer therapy
	MJ Ratain, RL Schilsky, BA Conley, and MJ Egorin
	JCO Oct 1 1990: 1739–1753. [Abstract] [PDF]
The American Society of Clinical Oncology: change, growth, and rebirth
RC Young
JCO Oct 1 1990: 1757–1766. [PDF]
Antibiotic prophylaxis to prevent catheter-related infections in recombinant interleukin-2-treated patients
C Orcese, A Borri, and C Besana
JCO Oct 1 1990: 1767–1768. [PDF]
Evidence of "stage shift" in IRS studies?
J Pritchard
JCO Oct 1 1990: 1768–1769. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.